B
EHC icon

Bayban’s Encompass Health EHC Stock Holding History

Bayban’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Hold
11
– – ﹤0.01% 560
2026
Q1 		$1.06K Buy
+11
New +$1.13K ﹤0.01% 614

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bayban's EHC Position: Q2 2026 in Review

Bayban held its Encompass Health (EHC) position steady in Q2 2026 at 11 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Bayban first reported a position in EHC in Q1 2026 and has held it in 2 quarters since. 562 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Bayban held 11 shares of Encompass Health worth $1.11K as of Q2 2026.
  • Bayban left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up ﹤0.01% of Bayban's portfolio in Q2 2026, its #560 holding.
  • Bayban first reported a position in Encompass Health in Q1 2026 and has held it in 2 quarters since.
  • 562 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.